Genomic Epidemiology of Carbapenem-Resistant in Qatar: Emergence and Dissemination of Hypervirulent Klebsiella Pneumoniae Sequence Type 383 Strains
Overview
Authors
Affiliations
The emergence of carbapenem-resistant, hypervirulent Klebsiella pneumoniae is a new threat to health care. We studied the molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae isolates in Qatar using whole-genome sequence data. We also characterized the prevalence and genetic basis of hypervirulent phenotypes and established the virulence potential using a Galleria mellonella model. Of 100 Klebsiella isolates studied, NDM and OXA-48 were the most common carbapenemases. Core genome single-nucleotide polymorphism (SNP) analysis indicated the presence of diverse sequence types and clonal lineages; isolates belonging to Klebsiella quasipneumoniae subsp. sequence type 196 (ST196) and ST1416 may be disseminated among several health care centers. Ten K. pneumoniae isolates carried and/or truncated , and 2 isolates belonged to KL2, indicating low prevalence of classical hypervirulent isolates. Isolates carrying both carbapenem resistance and hypervirulence genes were confined mainly to ST231 and ST383 isolates. One ST383 isolate was further investigated by MinION sequencing, and the assembled genome indicated that was located on an IncHI1B-type plasmid (pFQ61_ST383_NDM-5) which coharbored several virulence factors, including the regulator of the mucoid phenotype (), the regulator of mucoid phenotype 2 (), and aerobactin ( and ), likely resulting from recombination events. Comparative genomics indicated that this hybrid plasmid may be present in two additional Qatari ST383 isolates. Carbapenem-resistant, hypervirulent K. pneumoniae ST383 isolates pose an emerging threat to global health due to their simultaneous hypervirulence and multidrug resistance.
Prevalence and features of hypervirulent in respiratory specimens at a US hospital system.
McElheny C, Iovleva A, Chen N, Woods D, Pradhan A, Sonnabend J Infect Immun. 2024; 93(1):e0048624.
PMID: 39660916 PMC: 11784238. DOI: 10.1128/iai.00486-24.
Characterization of in two ST1193 clinical isolates in the Gulf region.
Tsui C, Ben Abid F, McElheny C, Hamed M, Perez-Lopez A, Omrani A JAC Antimicrob Resist. 2024; 6(6):dlae166.
PMID: 39507943 PMC: 11538964. DOI: 10.1093/jacamr/dlae166.
Yu J, Ding Y, Zhang X, Tai S, Zhang C, Liu C Infect Drug Resist. 2024; 17:3945-3953.
PMID: 39290510 PMC: 11407308. DOI: 10.2147/IDR.S478304.
Sobh G, Araj G, Finianos M, Sourenian T, Hrabak J, Pappagianitsis C Front Cell Infect Microbiol. 2024; 14:1407246.
PMID: 38962322 PMC: 11219574. DOI: 10.3389/fcimb.2024.1407246.
Hadi H, Dargham S, Eltayeb F, Ali M, Suliman J, Ahmed S Antibiotics (Basel). 2024; 13(4).
PMID: 38666996 PMC: 11047403. DOI: 10.3390/antibiotics13040320.